Stryker stock skidded Wednesday — despite reporting solid 10% organic sales growth — due to lighter-than-expected revenue from knee replacements. Please watch the video at Investors.com - How ...

Over the last decade, Stryker's market share in knee implants has hovered around 22%, and Zimmer Biomet and DePuy have held share at 30% and 19%, respectively, by our estimates. The most common ...